Welcome to LookChem.com Sign In|Join Free

CAS

  • or

101-31-5

Post Buying Request

101-31-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

101-31-5 Usage

Chemical Properties

White to Off-White Solid

Uses

Different sources of media describe the Uses of 101-31-5 differently. You can refer to the following data:
1. L-Hyoscyamine is a natural compound that has inhibitory activity against cholinesterases.
2. L-Hyoscyamine can be used as anticholinergic and analgesic.
3. Suggested starting dilutions are as follows: IHC-P: 1:100-1:1000, WB: 1:1000-1:10000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user.

Definition

ChEBI: An atropine with a 2S-configuration.

General Description

Hyoscyamine is a levorotatory alkaloidobtained from various solanaceous species. One ofthe commercial sources is Egyptian henbane (Hyoscyamusmuticus), in which it occurs to the extent of about 0.5%.Usually, it is prepared from the crude drug in a manner similarto that used for atropine and is purified as the oxalate.The free base is obtained easily from this salt.It occurs as white needles that are sparingly soluble inwater (1:281), more soluble in ether (1:69) or benzene(1:150), very soluble in chloroform (1:1), and freely solublein alcohol. It is used as the sulfate and hydrobromide. Theprincipal reason for the popularity of the hydrobromide hasbeen its nondeliquescent nature. The salts have the advantageover the free base in being quite water soluble.

Biochem/physiol Actions

The 21st amino acid, selenocysteine (sec), is distinct from other amino acids because it lacks its own tRNA synthetase and is the only amino acid synthesized on its cognate tRNA. Synthesis of sec begins with acylation of tRNA(sec) (TRSP; MIM 165060) by seryl-tRNA synthetase (SARS; MIM 607529) to give ser-tRNA(sec), which is subsequently phosphorylated by O-phosphoseryl-tRNA kinase (PSTK; MIM 611310) to give O-phosphoseryl-tRNA(sec). SEPSECS catalyzes the final step of sec synthesis by converting O-phosphoseryl-tRNA(sec) to selenocysteinyl-tRNA(sec) using selenophosphate as the selenium donor (Palioura et al., 2009 [PubMed 19608919]).[supplied by OMIM]

Clinical Use

(L-Hyoscyamine)Hyoscyamine is used to treat disorders of the urinarytract more so than any other antispasmodic, although thereis no evidence that it has any advantages over the otherbelladonna preparations and the synthetic anticholinergics.It is used to treat spasms of the bladder and, in this manner,serves as a urinary stimulant. It is used together witha narcotic to counteract the spasm produced by the narcoticwhen the latter is used to relieve the pain of urethral colic.Hyoscyamine preparations are also used as antispasmodicsin the therapy of peptic ulcers.

Check Digit Verification of cas no

The CAS Registry Mumber 101-31-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,0 and 1 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 101-31:
(5*1)+(4*0)+(3*1)+(2*3)+(1*1)=15
15 % 10 = 5
So 101-31-5 is a valid CAS Registry Number.
InChI:InChI=1/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15+,16-/m1/s1

101-31-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (H0450)  (-)-Hyoscyamine  >99.0%(T)

  • 101-31-5

  • 5g

  • 1,290.00CNY

  • Detail
  • Sigma-Aldrich

  • (37021)  L-Hyoscyamine  analytical standard

  • 101-31-5

  • 37021-0.1MG

  • 9,652.50CNY

  • Detail

101-31-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-atropine

1.2 Other means of identification

Product number -
Other names Hyoscyamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:101-31-5 SDS

101-31-5Synthetic route

hyoscine hydrobromide
114-49-8

hyoscine hydrobromide

A

(3S,6S,2'S)-6β-hydroxyhyoscyamine
55869-99-3

(3S,6S,2'S)-6β-hydroxyhyoscyamine

B

(3R,6R,2'S)-6β-hydroxyhyoscyamine
126371-43-5

(3R,6R,2'S)-6β-hydroxyhyoscyamine

C

Hyoscyamine
101-31-5

Hyoscyamine

Conditions
ConditionsYield
With hydrogen; Nickel Raney W1A 41.7%
B 33.9%
C 19.7%
(S)-tropic acid
16202-15-6

(S)-tropic acid

3-tropanol
120-29-6

3-tropanol

Hyoscyamine
101-31-5

Hyoscyamine

Conditions
ConditionsYield
With hydrogenchloride und Darstellung;
(1S)-10-camphorsulfonic acid
3144-16-9

(1S)-10-camphorsulfonic acid

atropine
51-55-8

atropine

Hyoscyamine
101-31-5

Hyoscyamine

Conditions
ConditionsYield
Man unterwirft das entstehende Salz einer fraktionierten Krystallisation aus alkoholhaltigem Essigester;
atropine
51-55-8

atropine

A

(+)-Atropine
13269-35-7

(+)-Atropine

B

Hyoscyamine
101-31-5

Hyoscyamine

Conditions
ConditionsYield
resolving agent: trans-cellulose tris(4-phenylazophenylcarbamate) ( CPAPC ) adsorbed on silica gel; optical resolution degree examined by HPLC on cis/trans-CPAPC;
Conditions
ConditionsYield
With hydrogen; nickel In water at 20℃; for 19h;A 150 mg
B 150 mg
C 290 mg
(-)-Littorine

(-)-Littorine

Hyoscyamine
101-31-5

Hyoscyamine

Conditions
ConditionsYield
With sodium (RS)-phenyl<2-(18)O,2-(2)H>acetate; Datura stramonium root cultures for 264h; Mechanism; different reaction times;
methyl iodide
74-88-4

methyl iodide

nor-l-hyoscyamine

nor-l-hyoscyamine

Hyoscyamine
101-31-5

Hyoscyamine

Conditions
ConditionsYield
With methanol
Conditions
ConditionsYield
With triethylamine In aq. phosphate buffer; acetonitrile at 10℃; pH=7.0; Thermodynamic data; pH-value; Reagent/catalyst; Solvent; Temperature; Resolution of racemate;
Atropine
51-55-8

Atropine

A

(+)-Atropine
13269-35-7

(+)-Atropine

B

Hyoscyamine
101-31-5

Hyoscyamine

Conditions
ConditionsYield
With β‑cyclodextrin sulfonic acid In aq. phosphate buffer at 25℃; pH=3; pH-value; Reagent/catalyst; Resolution of racemate;
ethanol
64-17-5

ethanol

Hyoscyamine
101-31-5

Hyoscyamine

atropine
51-55-8

atropine

Conditions
ConditionsYield
bei langem Aufbewahren;
in Gegenwart von Natriumhydroxyd oder anderen Basen;
acetic anhydride
108-24-7

acetic anhydride

Hyoscyamine
101-31-5

Hyoscyamine

apoatropine
500-55-0

apoatropine

Conditions
ConditionsYield
at 85℃;
benzoic acid anhydride
93-97-0

benzoic acid anhydride

Hyoscyamine
101-31-5

Hyoscyamine

apoatropine
500-55-0

apoatropine

Conditions
ConditionsYield
at 85℃;
Hyoscyamine
101-31-5

Hyoscyamine

(+/-)-1-phenyl-1,2,3,4-tetrahydro-naphthalene-1r,4t-dicarboxylic acid di-tropane-3endo-yl ester
510-25-8, 5878-33-1, 6696-63-5, 23852-32-6

(+/-)-1-phenyl-1,2,3,4-tetrahydro-naphthalene-1r,4t-dicarboxylic acid di-tropane-3endo-yl ester

Conditions
ConditionsYield
at 120 - 130℃;
Hyoscyamine
101-31-5

Hyoscyamine

atropine
51-55-8

atropine

Conditions
ConditionsYield
(-)-hyoscyamine;
3β-bromoacetoxy-5,14-dihydroxy-19-oxo-5β,14β-card-20(22)-enolide
4956-18-7

3β-bromoacetoxy-5,14-dihydroxy-19-oxo-5β,14β-card-20(22)-enolide

Hyoscyamine
101-31-5

Hyoscyamine

3β-O-(hyoscaminioacetyl)strophantidin bromide

3β-O-(hyoscaminioacetyl)strophantidin bromide

sulfuric acid
7664-93-9

sulfuric acid

Hyoscyamine
101-31-5

Hyoscyamine

(+/-)-1-phenyl-1,2,3,4-tetrahydro-naphthalene-1r,4t-dicarboxylic acid di-tropane-3endo-yl ester
510-25-8, 5878-33-1, 6696-63-5, 23852-32-6

(+/-)-1-phenyl-1,2,3,4-tetrahydro-naphthalene-1r,4t-dicarboxylic acid di-tropane-3endo-yl ester

Hyoscyamine
101-31-5

Hyoscyamine

aq. barium hydroxide solution

aq. barium hydroxide solution

A

Tropic acid
529-64-6

Tropic acid

B

3-tropanol
120-29-6

3-tropanol

Conditions
ConditionsYield
at 60℃;
water
7732-18-5

water

Hyoscyamine
101-31-5

Hyoscyamine

A

(S)-tropic acid
16202-15-6

(S)-tropic acid

B

3-tropanol
120-29-6

3-tropanol

Conditions
ConditionsYield
bei laengerem Aufbewahren;
beim Kochen.Hydrolysis;
hydrogenchloride
7647-01-0

hydrogenchloride

Hyoscyamine
101-31-5

Hyoscyamine

A

3-chloro-8-methyl-8-azabicyclo[3.2.1]octane
2292-12-8

3-chloro-8-methyl-8-azabicyclo[3.2.1]octane

B

(-)-tropic acid

(-)-tropic acid

Conditions
ConditionsYield
at 140℃; (-)-hyoscyamine;
sulfuric acid
7664-93-9

sulfuric acid

Hyoscyamine
101-31-5

Hyoscyamine

apoatropine
500-55-0

apoatropine

101-31-5Related news

Sublingual L-Hyoscyamine (cas 101-31-5) for duodenal antimotility during ERCP: a prospective randomized double-blinded study08/06/2019

BackgroundERCP is often made difficult by duodenal motility. Glucagon is typically used to inhibit this motility. L-hyoscyamine is an antimuscarinic, anticholinergic agent shown to be a feasible intravenous alternative to glucagon.detailed

Comparative study between magnesium sulphate and L-Hyoscyamine (cas 101-31-5) on duodenal motility during ERCP under general anaesthesia: A prospective randomized study08/04/2019

ObjectiveEndoscopic retrograde cholangiopancreatography (ERCP) is a relatively complex procedure as compared with other endoscopy which needs longer duration, duodenal relaxation and good sedation. The aim of this study was to evaluate the efficacy and safety of magnesium sulphate as spasmolytic...detailed

101-31-5Relevant articles and documents

Absolute configuration of natural diastereoisomers of 6β- hydroxyhyoscyamine by vibrational circular dichroism

Munoz, Marcelo A.,Munoz, Orlando,Joseph-Nathan, Pedro

, p. 1335 - 1340 (2006)

The absolute configuration of the two natural diastereoisomers of 6β-hydroxyhyoscyamine has been determined using vibrational circular dichroism (VCD) spectroscopy. The predicted VCD and IR spectra of (3R,6R,2′S)-6β-hydroxyhyoscyamine (1) and (3S,6S,2′S)-6β- hydroxyhyoscyamine (2) were calculated using density functional theory (DFT) with the B3LYP functional and 6-31G(d) basis set and considering the eight lower energy conformations of each diastereoisomer. In both cases, the first four conformers showed the N-Me group in the syn orientation, permitting the formation of a hydrogen bond between the hydroxy group at the tropane ring and the tertiary nitrogen atom. In addition the eight conformers showed an intramolecular hydrogen bond between the hydroxy and carbonyl groups of the tropic ester moiety. The calculated IR spectra of both molecules showed good agreement with the experimental spectra, while comparison of the experimental and calculated VCD spectra showed that the absolute configuration of dextrorotatory 6β-hydroxyhyoscyamine is (3R,6R,2′S), while the levorotatory isomer is (3S,6S,2′S).

Tropic acid biosynthesis: The incorporation of (RS)-phenyl[2-18O,2-2H]lactate into littorine and hyoscyamine in Datura stramonium

Wong, Chi W.,Hamilton, John T. G.,O'Hagan, David,Robins, Richard J.

, p. 1045 - 1046 (1998)

The incorporation of oxygen-18 from (RS)-phenyl-[2-18O,2-2H]lactate into the tropane alkaloids littorine 1 and hyoscyamine 2 in Datura stramonium reveals that up to 29% of the oxygen-18 is lost during the transformation of 1 to 2.

-

Schmidt et al.

, p. 1453,1454 (1967)

-

Comparison of three S-β-CDs with different degrees of substitution for the chiral separation of 12 drugs in capillary electrophoresis

Wang, Zhaokun,Zhang, Qiongwen,Luo, Linda,Sun, Tiemin,Guo, Xingjie

, p. 558 - 565 (2017/08/26)

Three kinds of sulfated β-cyclodextrin (S-β-CD), including a single isomer, heptakis-6-sulfato-β-cyclodextrin (HS-β-CD), degree of substitution (DS) of 7, which was synthesized in our laboratory and another two commercialized randomly substituted mixtures, a sulfated β-cyclodextrin with DS of 7 to 11, as well as a highly sulfated-β-cyclodextrin with DS of 12 to 15, were used for the enantioresolution of 12 drugs (the β-blockers, phenethylamines, and anticholinergic agents) in capillary electrophoresis. The enantioseparation under varying concentrations of S-β-CD and background electrolyte pH were systematically investigated and compared. Based on the experimental results, the effect of the nature of S-β-CD and analyte structure on the enantioseparation is discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 101-31-5